Life Sciences

  If you visit the Gloucester Police Department’s Facebook page, you’ll notice their posts from September 16th and 18th received thousands of likes, shares, and comments. That’s for good reason. On September 16th, the department called out five pharma CEOs with the highest salaries and urged readers to contact them and ask what they’re doing […]

  Turing Pharmaceuticals, the maker of Daraprim, a drug that treats toxoplasmosis (a parasitic disease), increased the cost of each tablet from $13.50 to $750. That’s right – more than a 5,000% increase. 

  Last time, we discussed how Oracle’s drug safety and pharmacovigilance system provides workflow configurations that can handle internal quality control, quality assurance and/or quality management issues. Today, we’ll talk about how Argus Safety supports rule #2. 

  Digital transformation (DT), the concept of leveraging digital technologies to engage with constituents (e.g., customers, patients, employees, or partners) is vital in today’s world. The audience you’re targeting expects communication to be easy and information to be readily available at any time. If they can’t get what they want from you, they’ll go somewhere […]

  These days, it appears as if most of the big contract research organizations (CROs) are using Siebel CTMS, Oracle’s clinical trial management system. In June of this year, I wrote about Quintiles’ use of Oracle Health Sciences applications, including Siebel CTMS. Now we’re talking about PPD, another top-5 CRO. 

  According to the September/October edition of the Impact Report released by the Tufts Center for the Study of Drug Development (CSDD), the reporting of adverse events (AEs) by healthcare professionals is inadequate. In particular, regulatory submissions are an issue due to the lack of critical information provided on submission forms, which can inadvertently alter […]

  We often hear the term “rare disease,” yet many of us still wonder exactly how “rare” is defined. In a recent blog post, Dr. Jonathan Goldsmith, the FDA’s Associate Director for Rare Diseases, shared some staggering statistics, as well as insights into how the FDA is making it easier to develop drugs for unusual […]

  Life sciences organizations are in the business of developing drugs and medical devices. Hitting key milestones and moving trials to the next phase has always been a priority. Throughout this entire process, the collection and analysis of clinical and safety data is essential in taking products to subsequent stages, and ultimately getting them approved […]

  As many of you know, Perficient has a practice devoted to Salesforce.com solutions. So, it shouldn’t be a surprise that a bunch of my colleagues are at this year’s Dreamforce event and furiously blogging about what they’re hearing. One of the posts that caught my attention was from Mike Porter, who sat in Dr. […]

  It seems like every other day we’re reading about pharmaceutical companies developing mobile apps, or at the very least, investing in companies that develop them. And that’s for good reason: They work. They help researchers learn about disorders. They help educate patients on their conditions and provide treatment recommendations. They help with patient adherence. […]

  Over the last few posts, we’ve discussed CAPAs at a very high level. Now we’ll move on to discussing Oracle Argus Safety’s ability to comply with various CAPA rules. CAPA Rule: System must provide workflow configuration to handle internal quality control, quality assurance and/or quality management issues How does Argus Safety support this rule? 

  Keith Lovell just left Shazam, the company behind the popular app that magically tells you the artist performing the song playing in the background at Cheesecake Factory. With almost a decade as the company’s CFO, he chose to join TrialReach, a technology company focused on helping patients find the clinical trials they’re eligible for, based on […]